Also known as: Migraine with or without Aura
Migraine is a neurological condition characterized by intense, throbbing headaches that often affect one side of the head. Episodes can last from hours to days and may be accompanied by sensory disturbances known as aura, including visual changes or tingling sensations.
Migraine is a complex neurological disorder that affects approximately 12% of the global population, making it one of the most prevalent and disabling conditions worldwide. Unlike ordinary headaches, migraines involve a cascade of neurochemical changes in the brain that produce intense, often debilitating pain typically concentrated on one side of the head. The condition is significantly more common in women than in men, largely due to hormonal influences, and most commonly presents between the ages of 25 and 55.
Migraines are classified into two major subtypes: migraine with aura and migraine without aura. Aura refers to reversible neurological symptoms that typically precede the headache phase and may include visual disturbances such as flashing lights, zigzag lines, or temporary blind spots, as well as sensory changes like tingling in the face or hands. The headache phase itself is characterized by moderate to severe pulsating pain that worsens with physical activity and is frequently accompanied by nausea, vomiting, and extreme sensitivity to light, sound, and sometimes smell.
The pathophysiology of migraines involves activation of the trigeminovascular system, cortical spreading depression, and alterations in neurotransmitter levels including serotonin and calcitonin gene-related peptide (CGRP). Triggers vary widely among individuals but commonly include stress, hormonal fluctuations, certain foods and beverages, sleep disruption, weather changes, and sensory stimuli. Understanding and identifying personal triggers is a critical component of migraine management and can significantly reduce the frequency and severity of attacks.
People with Migraine often experience the following symptoms.
Intense, rhythmic pain usually affecting one side of the head, though it can occur bilaterally. The pain typically worsens with physical movement and can last from 4 to 72 hours if untreated.
Gastrointestinal disturbance is extremely common during migraines, occurring in up to 80% of sufferers. Nausea can be severe enough to prevent oral medication intake, sometimes necessitating alternative treatment routes.
Heightened sensitivity to light and sound is a hallmark of migraine. Patients often retreat to dark, quiet rooms during an attack because normal light and sound levels become intensely uncomfortable.
Approximately 25-30% of migraine sufferers experience aura, most commonly visual disturbances such as flashing lights, shimmering zigzag lines, blind spots, or temporary partial vision loss. These symptoms typically develop over 5-20 minutes and resolve within an hour.
Tingling or numbness that often starts in one hand and gradually spreads up the arm to the face. Some patients also experience speech difficulties or word-finding problems during the aura phase.
Many migraine sufferers notice warning signs hours or even days before an attack, including mood changes, food cravings, neck stiffness, increased yawning, frequent urination, and fluid retention.
Often referred to as 'brain fog,' this includes difficulty concentrating, confusion, and slowed thinking. These cognitive symptoms can persist during the postdrome phase for up to 48 hours after the headache resolves.
Some patients experience vestibular migraine, where episodes include significant dizziness, balance problems, and vertigo that may occur with or without headache pain.
Certain factors may increase your likelihood of developing Migraine.
Common approaches to managing migraine. Always consult a healthcare provider for personalized treatment.
Triptans such as sumatriptan and rizatriptan are first-line treatments for moderate to severe migraines. They work by stimulating serotonin receptors to constrict blood vessels and block pain pathways. Most effective when taken early in an attack.
Newer medications targeting calcitonin gene-related peptide (CGRP), including erenumab, fremanezumab, and galcanezumab, are used for migraine prevention. Gepants such as ubrogepant and rimegepant can also be used for acute treatment.
NSAIDs like ibuprofen and naproxen, as well as combination analgesics containing acetaminophen, aspirin, and caffeine, can be effective for mild to moderate migraines. These should be used cautiously to avoid medication overuse headache.
Beta-blockers (propranolol), anticonvulsants (topiramate), antidepressants (amitriptyline), and botulinum toxin injections (Botox) may be prescribed for patients with frequent migraines to reduce attack frequency and severity.
Maintaining regular sleep schedules, managing stress through relaxation techniques and exercise, staying hydrated, and identifying and avoiding personal dietary and environmental triggers form the foundation of migraine management.
FDA-cleared devices such as transcutaneous supraorbital nerve stimulation (Cefaly), single-pulse transcranial magnetic stimulation, and noninvasive vagus nerve stimulation offer drug-free options for both acute treatment and prevention of migraines.
Migraine is primarily diagnosed through clinical evaluation based on the patient's medical history, symptom description, and a thorough neurological examination. Physicians use the International Classification of Headache Disorders (ICHD) criteria, which require at least five attacks lasting 4-72 hours with specific characteristics including unilateral location, pulsating quality, moderate to severe intensity, and aggravation by routine physical activity, plus at least one associated symptom such as nausea or photophobia. Brain imaging with MRI or CT scan is not routinely required but may be ordered to rule out secondary causes if headaches are atypical, suddenly change in pattern, are accompanied by neurological deficits, or begin after age 50. Keeping a detailed headache diary that records frequency, duration, triggers, and associated symptoms is invaluable for accurate diagnosis and treatment planning.
Seek immediate medical attention if you experience a sudden, severe headache unlike any you have had before, a headache accompanied by fever, stiff neck, confusion, seizures, double vision, weakness, numbness, or difficulty speaking. These could indicate a more serious condition such as meningitis, stroke, or aneurysm. Also see a doctor if your migraines become more frequent, are not responding to treatment, or significantly interfere with your daily activities.
Steps that may help reduce the risk of developing or worsening migraine.
Maintain consistent sleep and wake times, aiming for 7-8 hours of quality sleep each night
Practice regular stress management techniques such as yoga, meditation, deep breathing exercises, or progressive muscle relaxation
Keep a detailed migraine diary to identify and avoid personal triggers including specific foods, beverages, environmental factors, and hormonal patterns
Stay well hydrated and maintain regular meal schedules, avoiding prolonged fasting which can trigger attacks
Engage in regular moderate aerobic exercise such as brisk walking, swimming, or cycling for at least 150 minutes per week
If left untreated or poorly managed, migraine may lead to:
Migraines are a neurological condition involving complex brain changes, while regular headaches typically involve muscle tension or sinus pressure. Migraines produce moderate to severe throbbing pain usually on one side, are accompanied by nausea, light and sound sensitivity, and may include visual aura. They are significantly more disabling, can last up to 72 hours, and worsen with physical activity, unlike tension headaches which produce a dull, bilateral pressure.
There is currently no permanent cure for migraines, but the condition can be effectively managed. Many patients achieve significant reduction in attack frequency and severity through a combination of preventive medications, lifestyle modifications, trigger avoidance, and acute treatments. Newer therapies targeting CGRP have shown particularly promising results. Some patients experience natural improvement over time, especially after hormonal changes such as menopause.
Yes, migraines have a strong genetic component. If one parent has migraines, a child has approximately a 50% chance of developing them; if both parents are affected, the risk increases to about 75%. Researchers have identified multiple genes involved in migraine susceptibility, though the condition results from a complex interaction between genetic predisposition and environmental factors.
Common dietary triggers include aged cheeses, processed meats containing nitrates, chocolate, alcohol (especially red wine), foods containing MSG, artificial sweeteners like aspartame, and caffeine (both excessive intake and withdrawal). However, triggers vary greatly between individuals, and keeping a food diary is the best way to identify personal dietary triggers. Not all migraine sufferers have food triggers.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.